CA Patent

CA2696063C — Immediate release and sustained release ibuprofen dosing form

Assigned to Kenvue Brands LLC · Expires 2014-05-06 · 12y expired

What this patent protects

A method of administering non-steroidal-anti-inflammatory drugs, in particular propionic acid derivatives such as ibuprofen, is provided. The inventive dosage forms provide an initial release of the NSAID and a second sustained release of NSAID, preferably in a single dosing step…

USPTO Abstract

A method of administering non-steroidal-anti-inflammatory drugs, in particular propionic acid derivatives such as ibuprofen, is provided. The inventive dosage forms provide an initial release of the NSAID and a second sustained release of NSAID, preferably in a single dosing step.

Drugs covered by this patent

Patent Metadata

Patent number
CA2696063C
Jurisdiction
CA
Classification
—
Expires
2014-05-06
Drug substance claim
No
Drug product claim
No
Assignee
Kenvue Brands LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.